Y 904
Latest Information Update: 27 Jun 2002
At a glance
- Originator Mitsubishi Pharma Corporation
- Class Antibacterials; Fluoroquinolones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Helicobacter infections
Most Recent Events
- 01 Jun 2000 New profile
- 01 Jun 2000 Preclinical development for Helicobacter infections in Japan (Unknown route)